Vimarsana
Biggest News Aggregation in the World

Page 25 - Engineering Laboratory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Engineering Laboratory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Engineering Laboratory Today - Breaking & Trending Today

Organs-On-Chips Market size worth $ 300.89 Million, Globally, by 2028 at 36.90% CAGR: Verified Market Research® - Vimarsana News

Organs-On-Chips Market size worth $ 300.89 Million, Globally, by 2028 at 36.90% CAGR: Verified Market Research®

/PRNewswire/ -- Verified Market Research recently published a report, "Organs-On-Chips Market" By End-User (Pharmaceutical & Biotechnology Companies, Academic...

Organs-On-Chips Market size worth $ 300.89 Million, Globally, by 2028 at 36.90% CAGR: Verified Market Research - Vimarsana News

Organs-On-Chips Market size worth $ 300.89 Million, Globally, by 2028 at 36.90% CAGR: Verified Market Research

Significant increase in research funding and venture capital investments for the development of Organs-on-Chips, as well as a growing focus on developing alternatives for animal testing models

Green hydrogen: Inside Scotland's growing industry for zero-carbon fuel - Vimarsana News

Green hydrogen: Inside Scotland's growing industry for zero-carbon fuel

Hydrogen is quickly emerging as a potential solution to help ease the global energy crisis and enable nations to increase energy security.

Top Prospects: Leading innovators from the Class of 2022 - Vimarsana News

Top Prospects: Leading innovators from the Class of 2022

For the fifth year in a row, The Logic reached out to Canada’s top engineering and computer-science schools to find out which rising stars are on their way…

Biotechnology platforms enable fast, customizable vaccine production - Vimarsana News

Biotechnology platforms enable fast, customizable vaccine production

When COVID-19 created an urgent need for vaccines that could be made quickly, safely and cost-effectively, traditional manufacturing approaches were not sufficient to meet the demand. Biopharmaceutical companies therefore shifted to novel biotechnology platform-based techniques that could be more quickly adapted to manufacture COVID-19 vaccines, and that were more robust, customizable and flexible than traditional approaches. An examination of this transition by a Penn State-led team concludes that such smart manufacturing techniques could in the future be applied to other viruses, potentially...

Source: psu.edu